19 insiders reported 196 Form 4 transactions for NEUROCRINE BIOSCIENCES INC (NBIX) over the past 18 months (most recent 2026-08-05). Recent activity: Onyia Jude (Chief Scientific Officer) Sell 2,409 shares, Norwalk Leslie V (Director) Sell 1,250 shares, Norwalk Leslie V (Director) Buy 842 shares, Delaet Ingrid (Chief Regulatory Officer) Buy 4,367 shares, Lippoldt Darin (Chief Legal Officer) Buy 10,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Onyia Jude | Chief Scientific Officer | Sell | 2,409 | $0 |
| 2026-07-30 | Norwalk Leslie V | Director | Sell | 1,250 | $227,508 |
| 2026-07-30 | Norwalk Leslie V | Director | Buy | 842 | $117,400 |
| 2026-07-13 | Delaet Ingrid | Chief Regulatory Officer | Buy | 4,367 | $462,989 |
| 2026-07-13 | Lippoldt Darin | Chief Legal Officer | Buy | 10,000 | $814,900 |
| 2026-07-13 | Lippoldt Darin | Chief Legal Officer | Sell | 10,000 | $1.8M |
| 2026-07-13 | Delaet Ingrid | Chief Regulatory Officer | Sell | 4,367 | $790,514 |
| 2026-07-09 | Delaet Ingrid | Chief Regulatory Officer | Sell | 8,433 | $1.5M |
| 2026-07-09 | Delaet Ingrid | Chief Regulatory Officer | Sell | 3,401 | $607,305 |
| 2026-07-09 | Delaet Ingrid | Chief Regulatory Officer | Buy | 2,737 | $283,334 |
| 2026-07-09 | Delaet Ingrid | Chief Regulatory Officer | Sell | 2,737 | $488,672 |
| 2026-07-09 | Delaet Ingrid | Chief Regulatory Officer | Buy | 3,401 | $352,072 |
| 2026-07-09 | Delaet Ingrid | Chief Regulatory Officer | Buy | 8,433 | $872,984 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Buy | 200 | $16,298 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Sell | 200 | $33,913 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Buy | 8,110 | $660,884 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Sell | 8,110 | $1.4M |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Buy | 1,690 | $137,718 |
| 2026-06-30 | Lippoldt Darin | Chief Legal Officer | Sell | 1,690 | $288,676 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 6,896 | $1.1M |
| 2026-06-09 | Onyia Jude | Chief Scientific Officer | Sell | 2,441 | $0 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Buy | 15,000 | $804,600 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Buy | 10,000 | $797,900 |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 7,883 | $1.3M |
| 2026-06-09 | SHERWIN STEPHEN A | Director | Sell | 2,549 | $419,156 |
Source: SEC Form 4 filings · as of 2026-08-05